WaferGen Bio Financial Ratios

WaferGen Bio systems Inc -- USA Stock  

USD 6.90  0.00  0.00%

Please harness WaferGen Bio systems fundamental data analysis to find out if markets are presently mispricing the firm. We found thirty-one available indicators for WaferGen Bio systems which can be compared to its rivals. To make sure the equity is not overpriced, please check out all WaferGen Bio systems fundamentals including its Price to Book, Cash Flow from Operations, Z Score, as well as the relationship between Cash and Equivalents and Total Asset . Given that WaferGen Bio systems has Number of Shares Shorted of 240.41 K, we strongly advise you confirm WaferGen Bio systems prevalent market performance to make sure the company can sustain itself down the road.Use WaferGen Bio to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of WaferGen Bio to be traded at $6.83 in 30 days

WaferGen Bio Company Summary

WaferGen Bio competes with Agilent Technologies, Ingersoll Rand, Sensata Technologies, Visualant Incorporated, and ELECTRO SENSORS. WaferGen Biosystems, Inc. develops, manufactures, and sells systems for singlecell analysis and clinical research in the United States, Canada, Europe, and the Asia Pacific.

WaferGen Bio Price to Sales vs Price to Earning

WaferGen Bio systems Inc is rated second in price to sales category among related companies. It is rated third in price to earning category among related companies .

WaferGen Bio systems Systematic Risk

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on WaferGen Bio systems correlated with the market. If Beta is less then 0 WaferGen Bio generally moves in the opposite direction as compared to the market. If WaferGen Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one WaferGen Bio systems is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of WaferGen Bio is generally in the same direction as the market. If Beta > 1 WaferGen Bio moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.
< 91% 

Chance of Financial Distress

WaferGen Bio systems Inc has more than 91 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

WaferGen Bio Thematic Clasifications

Active Ideas That Utilize WaferGen Bio systems
Measuring and Control Equipment IdeaMeasuring and Control EquipmentView


Compare WaferGen Bio To Peers


WaferGen Bio systems Inc Executive Managers
Rolland Carlson CEO and President and Director, Ph.D
Ivan Trifunovich Executive Chairman, Ph.D
More Executives